Cortexin
Polypeptide complex extracted from bovine/porcine cerebral cortex. Contains low-molecular-weight neuropeptides; marketed in Russia for cognitive recovery and pediatric neurology.
This compound sits in research-grey territory. The caveats below carry more weight than for FDA-approved entries — read them.
Geropharm (Russia) product. Approved in Russia and several CIS countries for stroke recovery, traumatic brain injury, encephalopathy in children. Western evidence is essentially absent. Often grouped with Cerebrolysin in biohacker discussions.
Animal-tissue origin (TSE concerns). Russian clinical literature dominates evidence base. Counterfeit and identity-verification risk in grey-market sources.
Per-claim grading. Each claim is graded independently — same peptide, different claims can carry different grades.
- DMechanistic / anecdotal
Cortexin — primary mechanism: polypeptide complex extracted from bovine/porcine cerebral cortex. contains low-molecular-weight neuropeptides; marketed in russia for cognitive recovery and pediatric neurology.
1 supporting referencesVerified 5d ago
External links to PubMed searches, ClinicalTrials.gov, and FDA materials. We do not host papers — we point at canonical sources.
Pre-filled with this compound's published dose range: 10 mg · daily IM, in 10-day cycles
Draw volume exceeds 100 units (1 mL). Either reduce dose or split into multiple injections.
Calculator is a discussion tool. Verify reconstitution + dosing with a qualified provider. Stack is not a prescription source. Use sterile technique and inspect every vial.
Approved in RU/CIS; not FDA-evaluated